TABLE 1.
Strain background | Description† | Number of isolates resolved
to |
|
---|---|---|---|
WT | ∆mucA | ||
PAO1 | Laboratory strain, Class II | 168 | 0* |
PA14 | Laboratory strain, Class I | 147 | 0* |
PA103 | Laboratory strain, unclassified | 361 | 0* |
PAK | Laboratory strain, unclassified | 191 | 0* |
CF127 | Mucoid CF isolate, unclassified | 136 | 0* |
CF18 | Non-mucoid CF isolate, unclassified | 129 | 0* |
CF27 | Rugose CF Isolate, Class IV | 152 | 0* |
X13273 | Blood isolate, Class II | 142 | 0* |
X24509 | UTI isolate, Class II | 221 | 0* |
MSH10 | Water isolate, Class III | 146 | 0* |
E2 | Tomato plant isolate, Class II | 141 | 0* |
*p < .0001, Fischer’s exact test.
†Class identification is based on the exopolysaccharide expression profile as described in (Colvin et al., 2012): Class I, Pel-dominant matrix; Class II, Psl-dominant matrix; Class III, exopolysaccharide redundant matrix users; and Class IV, matrix overproducers. CF, cystic fibrosis; UTI, urinary tract infection.